FeesSafety
Pluang+

BNB Chain leads blockchain growth with $3.7B in tokenized funds, dominating tokenized stocks and ETFs.

Protocol Fundamentals
26 Oct 2026, 23:05 WIB
Crypto Briefing
View Source
Bullish
BNB Chain leads blockchain growth with $3.7B in tokenized funds, dominating tokenized stocks and ETFs.

BNB Chain added $3.7 billion in tokenized fund market cap over the past year, outpacing all other blockchains. Its tokenized stocks and ETFs holdings surged to about $1.5 billion by mid-October 2026, capturing up to 42.6% of the $4 billion market. The chain hosts 1.8 million addresses holding tokenized stocks, representing 45% of all holders, with $25.6 billion in trading volume in Q3 2026. Growth is driven by Binance-affiliated platforms like Binance bStocks and Ondo Global Markets, highlighting strong demand for tokenized equities but also concentration risks in one ecosystem.

BNB Chain's tokenized fund market cap grew by $3.7 billion over the past year, leading all blockchains in this segment. For readers following cryptocurrency markets, here is Pluang's snapshot as of Oct 27, 2026 02:52 WIB: out of 50 major cryptocurrencies tradable on Pluang, 16 rose and 32 fell today. Notable movers include XNO (Nano) with a price of Rp6.077 and a 1-day change of +2.10%, FTM (Fantom) at Rp11.382 down 2.05%, and AAVE (Aave) at Rp2.441.203 down 1.81%, with AAVE showing 74% buy activity and a typical hold time of 106 days on Pluang.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
23 minutes ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
23 minutes ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
35 minutes ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
2 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App